Andere talen Actavia Life Sciences, Inc.

Aandelen

RASP

US7538881068

Beurs gesloten - OTC Markets Andere beurzen 20:18:48 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0016 ^USD	-82,22%		-82,22%	-79,22%

20/05	Actavia Life Sciences, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 maart 2024	CI
16/02	Actavia Life Sciences, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	20/05
Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	10/04
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	16/02
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	05/01
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	14-08-23
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15-05-23
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02-03-23
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	02-03-23
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	09-02-23
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	09-02-23
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	09-02-23
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	24-01-23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-01-23
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-12-22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-22
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-06-22
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	21-06-22
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16-06-22
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	16-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Actavia Life Sciences, Inc.

Aandelen

RASP

US7538881068

Andere talen

Filters